|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Receivables and prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-current Assets: | ||||||||||||||||||||
| Property and equipment at cost, net of accumulated depreciation | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued royalties | ||||||||||||||||||||
| Accrued expenses and other payables | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Convertible promissory notes, net | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Registration Rights Agreement liability | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-current Liabilities: | ||||||||||||||||||||
| Accrued severance | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||||||
| Preferred A Stock, $0.0001 par value, 12,500,000 shares authorized; 5,847,937 shares outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.0001 par value; 3,254,475,740 shares authorized; 976,997,116 and 956,997,116 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
Loading...
